Enhanced transduction of colonic cell lines in vitro and the inflamed colon in mice by viral vectors, derived from adeno-associated virus serotype 2, using virus-microbead conjugates bearing lectin

BMC Biotechnology

Volumn 7, Issue , 2007, Pages

  Farlow, Samuel J ^a,b   Jerusalmi, Alan ^a   Sano, Takeshi ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b AVEO ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; GENE EXPRESSION; PROTEINS; RATS; TISSUE; VIRUSES;

ADENO-ASSOCIATED VIRUS; COLON; GENE THERAPY; LECTIN;

GENE TRANSFER;

CARBOHYDRATE; CONCANAVALIN A; ENEMA; LECTIN; MANNOSE; PARVOVIRUS VECTOR; DRUG CARRIER; MICROSPHERE;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 2; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL SURFACE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN BINDING; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTIVITY; VIRUS PARTICLE; ANIMAL; CELL LINE; CHEMISTRY; COLON; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METHODOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

ADENO-ASSOCIATED VIRUS; MUS;

ANIMALS; CELL LINE; COLITIS; COLON; CONCANAVALIN A; DEPENDOVIRUS; DRUG CARRIERS; GENE THERAPY; GENETIC VECTORS; MICE; MICROSPHERES; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 38749093326     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-7-83     Document Type: Article

References (35)

1. Strober W Fuss IJ Blumberg RS The immunology of mucosal models of inflammation Annu Rev Immunol 2002, 20:495-549. 10.1146/ annurev.immunol.20.100301.064816 11861611
2. Podolsky DK Inflammatory bowel disease N Engl J Med 2002, 347:417-429. 10.1056/NEJMra020831 12167685
3. Bouma G Strober W The immunological and genetic basis of inflammatory bowel disease Nat Rev Immunol 2003, 3:521-533. 10.1038/nri1132 12876555
4. Korzenik JR Podolsky DK Evolving knowledge and therapy of inflammatory bowel disease Nat Rev Drug Discov 2006, 5:197-209. 10.1038/nrd1986 16518373
5. Wirtz S Galle PR Neurath MF Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure Gut 1999, 44:800-807. 1727540 10323880
6. Wirtz S Becker C Blumberg R Galle PR Neurath MF Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA J Immunol 2002, 168:411-420. 11751987
7. Lindsay JO Ciesielski CJ Scheinin T Brennan FM Hodgson HJ Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis Gut 2003, 52:981-987. 1773714 12801955 10.1136/gut.52.7.981
8. Jerusalmi A Farlow SJ Sano T Use of lectin as an anchoring agent for adenovirus-microbead conjugates: Application to the transduction of the inflamed colon in mice Gene Ther Mol Biol 2006, 10:223-232.
9. Izcue A Coombes JL Powrie F Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation Immunol Rev 2006, 212:256-271. 10.1111/j.0105-2896.2006.00423.x 16903919
10. Kurtovic J Segal I Recent advances in biological therapy for inflammatory bowel disease Trop Gastroenterol 2004, 25(9):14. 15303463
11. Li MC He SH IL-10 and its related cytokines for treatment of inflammatory bowel disease World J Gastroenterol 2004, 10:620-625. 14991925
12. Stokkers PC Hommes DW New cytokine therapeutics for inflammatory bowel disease Cytokine 2004, 28:167-173. 10.1016/j.cyto.2004.07.012 15588691
13. Wirtz S Neurath MF Inflammatory bowel disorders: Gene therapy solutions Curr Opin Mol Ther 2003, 5:495-502. 14601518
14. Braat H Peppelenbosch MP Hommes DW Interleukin-10-based therapy for inflammatory bowel disease Expert Opin Biol Ther 2003, 3:725-731. 10.1517/14712598.3.5.725 12880373
15. Asadullah K Sterry W Volk HD Interleukin-10 therapy - review of a new approach Pharmacol Rev 2003, 55:241-269. 10.1124/pr.55.2.4 12773629
16. Wirtz S Neurath MF Gene transfer approaches for the treatment of inflammatory bowel disease Gene Ther 2003, 10:854-860. 10.1038/ sj.gt.3302013 12732871
17. Ogata H Hibi T Cytokine and anti-cytokine therapies for inflammatory bowel disease Curr Pharm Des 2003, 9:1107-1113. 10.2174/1381612033455035 12769750
18. Veljaca M Anti-inflammatory peptides and proteins in inflammatory bowel disease Curr Opin Investig Drugs 2001, 2:1387-1394. 11890353
19. Sandborn WJ Transcending conventional therapies: The role of biologic and other novel therapies Inflamm Bowel Dis 2001, 7(Suppl 1):S9-16. 10.1002/ibd.3780070504 11380043
20. McCarty DM Young SM Jr. Samulski RJ Integration of adeno-associated virus (AAV) and recombinant AAV vectors Annu Rev Genet 2004, 38:819-845. 10.1146/annurev.genet.37.110801.143717 15568995
21. Carter BJ Adeno-associated virus and the development of adeno-associated virus vectors: A historical perspective Mol Ther 2004, 10:981-989. 10.1016/j.ymthe.2004.09.011 15564130
22. Flotte TR Adeno-associated virus-based gene therapy for inherited disorders Pediatr Res 2005, 58:1143-1147. 10.1203/ 01.pdr.0000189226.03684.fe 16306183
23. Li C Bowles DE van Dyke T Samulski RJ Adeno-associated virus vectors: potential applications for cancer gene therapy Cancer Gene Ther 2005, 12:913-925. 1361306 15962012 10.1038/sj.cgt.7700876
24. Wu Z Asokan A Samulski RJ Adeno-associated virus serotypes: Vector toolkit for human gene therapy Mol Ther 2006, 14:316-327. 10.1016/ j.ymthe.2006.05.009 16824801
25. Warrington KH Jr. Herzog RW Treatment of human disease by adeno-associated viral gene transfer Hum Genet 2006, 119:571-603. 10.1007/s00439-006-0165-6 16612615
26. Pandori M Hobson D Sano T Adenovirus-microbead conjugates possess enhanced infectivity: A new strategy for localized gene delivery Virology 2002, 29:204-212. 10.1006/viro.2002.1510 12202223
27. Pandori MW Sano T Chemically inactivated adenoviral vectors that can efficiently transduce target cells when delivered in the form of virus-microbead conjugates Gene Ther 2005, 12:521-533. 10.1038/ sj.gt.3302420 15703768
28. Green NM Avidin Adv Protein Chem 1970, 29:85-133.
29. Green NM Avidin and streptavidin Methods Enzymol 1990, 184:51-67. 2388586
30. Sano T Vajda S Reznik GO Smith CL Cantor CR Molecular engineering of streptavidin Ann N Y Acad Sci 1996, 799:383-390. 10.1111/ j.1749-6632.1996.tb33229.x 8958100
31. Wilchek M Bayer EA Foreword and introduction to the book (strept)avidin-biotin system Biomol Eng 1999, 16:1-4. 10.1016/ S1050-3862(99)00032-7 10796978
32. Hobson DA Pandori MW Sano T In situ transduction of target cells on solid surfaces by immobilized viral vectors BMC Biotechnol 2003, 3:4. 156648 12740047 10.1186/1472-6750-3-4
33. Jurjus AR Khoury NN Reimund JM Animal models of inflammatory bowel disease J Pharmacol Toxicol Methods 2004, 50:81-92. 10.1016/ j.vascn.2003.12.002 15385082
34. Mah C Fraites TJ Jr. Zolotukhin I Song S Flotte TR Dobson J Batich C Byrne BJ Improved method of recombinant AAV2 delivery for systemic targeted gene therapy Mol Ther 2002, 6:106-112. 10.1006/mthe.2001.0636 12095310
35. Zolotukhin S Byrne BJ Mason E Zolotukhin I Potter M Chesnut K Summerford C Samulski RJ Muzyczka N Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield Gene Ther 1999, 6:973-985. 10.1038/sj.gt.3300938 10455399